GlaxoSmithKline fined €380m over bribery in China

A court has fined British drug maker GlaxoSmithKline three billion yuan (€380m) and sentenced its British former manager in China and others to prison for bribing doctors and hospitals to use its products, a state news agency reported.
The fine was the biggest ever imposed by a Chinese court, the Xinhua News Agency said.